Profit from new markets
The United States, Latin America and the Caribbean are considered good regions for the development of Clinical Trials, and we are here to help you enter the market.
The benefits
Highly Qualified Medical Professionals
Through our network of sites and doctors, we ensure that we have only the best doctors in the various medical specialties, with extensive knowledge in the area of research, health care and patient relations.
Great diversity of patients
Latin America has a population of approximately 600 million people, many of whom live in areas where state health services are saturated, so recruitment efforts can be optimized, radically improving health development.
Low competition for patients
Compared to the USA and EU, Sponsors and CRO competition for patients in Latin America is low. LATAM has a higher Patient-Compliance, and thanks to the high concentration of potential subjects, fewer sites will be required to conduct the study.
BRCR Latam
FDA FACT:
“Ensuring diversity in clinical trials is key to advancing health equity”
We are constantly expanding our network of sites, researchers, teams, to better serve sponsors and patients. We have a strong pressence in LATAM, serving Mexico, Ecuador, Puerto Rico, Guatemala, El Salvador, Honduras, Costa Rica, Panama, Peru, Brazil, Paraguay, Jamaica, and Dominican Republic.